U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. FDA Rare Disease Day 2020: Supporting the Future of Rare Disease Product Development - 02/24/2020 - 02/24/2020
  1. FDA Meetings, Conferences and Workshops

Meeting | Mixed

Event Title
FDA Rare Disease Day 2020: Supporting the Future of Rare Disease Product Development
February 24, 2020

February 24, 2020
Event Location
White Oak Campus: The Great Room
Conference Center

10903 New Hampshire Ave
Building 31, Room 1503
Silver Spring, MD 20993
United States

Organized By:

The Food and Drug Administration (FDA or the Agency) is announcing a public meeting and an opportunity for public comment on “FDA Rare Disease Day 2020: Supporting the Future of Rare Disease Product Development.” Developing a treatment for a rare disease can present unique challenges. The goal of this meeting is to obtain stakeholder’s perspectives on challenges and solutions in rare disease product development and identify commonalities that can support product development across a variety of rare diseases.

Date and Location

February 24, 2020
9:00AM - 5:00PM EST.

The meeting will be held at:

FDA White Oak Campus
10903 New Hampshire Avenue
Building 31 Conference Center, Great Room
Silver Spring, MD 20993-0002

The entrance for public meeting participants (non-FDA employees or contractors) is through Building 1, where routine security check procedures will be performed.

For parking, security and other visitor information, please refer to Public Meetings at the FDA White Oak Campus.

Meeting Information


Please register to attend the event in-person or via webcast at Eventbrite. If you need special accommodations, please contact Eleanor Dixon-Terry at 301-796-7634 or Eleanor.Dixon-Terry@fda.hhs.gov by February 17, 2020.

Submitting Comments

Regardless of attendance at the public meeting, you can submit electronic or written comments to the public docket by 11:59 PM on March 29, 2020. Submit electronic comments to Regulations.gov. Submit written comments to the Division of Docket’s Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date.

All comments must be identified with the docket number FDA-2019-N-5646. The FDA may post, without change, all comments received to Regulations.gov, including any personal information provided.


If you have questions about registering for the meeting, contact Eleanor Dixon-Terry, U.S. Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, phone: 301-348-1591, or email OOPDOrphanEvents@fda.hhs.gov.


Event Materials

Title File Type/Size
Agenda for Rare Disease Day 2020 pdf (67.86 KB)
RPD 2020 Transcript pdf (1.56 MB)
Back to Top